v3.26.1
Stockholders' Equity and Stock-Based Compensation - Summary of Company's Stock Option Activity Under the Plan (Detail) - 2020 Plan, 2024 Plan, and 2025 Equity Inducement Plan [Member]
6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Outstanding at December 31, 2025 | shares 943,092  
Granted | shares 260,000  
Exercised | shares (13,310)  
Cancelled | shares (91,821)  
Outstanding at June 30, 2026 | shares 1,097,961 943,092
Exercisable as of June 30, 2026 | shares 726,587  
Outstanding at December 31, 2025 | $ / shares $ 6.17  
Granted | $ / shares 8.68  
Exercised | $ / shares 5.07  
Cancelled | $ / shares 11.26  
Outstanding at June 30, 2026 | $ / shares 6.35 $ 6.17
Exercisable as of June 30, 2026 | $ / shares $ 5.62  
Weighted - average remaining contractual term 8 years 1 month 6 days 8 years
Weighted - average remaining contractual term 7 years 4 months 24 days  
Aggregate intrinsic value | $ $ 4,005,000 $ 412,000
Aggregate intrinsic value | $ $ 3,233